BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Enamine supplies DSI Poised Fragment and Analogue Libraries to Diamond Light Source and SGC Oxford

Product News

Diamond-SGC-iNEXT Poised Library supports rapid fragment elaboration for chemical probe and drug development.

READ MORE

Ziath to Showcase New Low-Profile 2D Barcode Scanner for Liquid Handling Systems at SLAS2018

Product News

The innovative camera-based technology of the DataPaq™ Mirage gives a compact scanner design for easy integration with laboratory automation systems.

READ MORE

Waters and Malvern Panalytical Collaborate to Improve Polymer Characterization

Product News

Coupling of technologies delivers advanced information with superior speed and resolution compared to traditional Gel Permeation Chromatography (GPC).

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE